Work

Correction to: Tcf‑1 protects anti‑tumor TCR‑engineered CD8+ T‑cells from GzmB mediated self‑destruction

Year: 2022

Type: erratum

Source: Cancer Immunology Immunotherapy

DOI: 10.1007/s00262-022-03233-1

Authors: Brendan Zangari, Takemasa Tsuji, Junko Matsuzaki, Hemn Mohammadpour, Cheryl Eppolito, Sebastiano Battaglia, Fumito Ito, Thinle Chodon, Richard Koya, A. J. Robert McGray, Kunle Odunsi

Institutions: Roswell Park Comprehensive Cancer Center, University of Chicago, University of Chicago Medicine Comprehensive Cancer Center, University of Southern California

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $4,190

OpenAlex ID: W4281635177

Cites:

Cited by:

Related to: 10